Fear of repeated injections in children younger than 4 years receiving subcutaneous allergy immunotherapy.

ABSTRACT:

Background

Allergy immunotherapy during early childhood may have potential benefits for the prevention of asthma and allergy morbidity. However, subcutaneous immunotherapy has not yet been prospectively researched in children younger than 4 years, primarily because of safety concerns, including the fear and psychological distress young children may experience with repeated needle injections.

Objective

To quantify fear in atopic children younger than 4 years with a history of wheezing who are receiving subcutaneous immunotherapy.

Methods

Fear of injection was graded during a total of 788 immunotherapy injection visits in 18 children (age, 37 months; SD, 9 months) receiving subcutaneous allergy immunotherapy. The parent and the injection nurse assigned fear scores on a

SUBMITTER: de Vos G 

PROVIDER: S-EPMC4529059 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature